Trimi's compounded tirzepatide uses the same active ingredient but is compounded per individual prescription under 503A pharmacy standards without FDA premarket review of the finished product
Cosmos Study December 16, 2025 Dual-Team Study Team A:Kersten Bartelt, RNNicholas Volker Team B:Tony Dunnigan, MDEric Barkley Key Findings Among patients with type 2 diabetes, GLP-1 use was associated with a 32% lower fracture risk for those with either osteopenia or osteoporosis
Over time, chronic energy deficiency can lead to fatigue, poor recovery, loss of muscle, hormonal disturbances, low energy availability and impaired performance a condition akin to RED-S (Relative Energy Deficiency in Sport)
Nat Commun 11 , 1272 (2020)
[DOI] [PMC free article] [PubMed] [Google Scholar] Hareter A, Hoffmann E, Bode HP, Gke B, Gke R
Switching GLP-1s Patients or clinicians might consider switching between weight-loss medications